Research progress of tumor vaccines in the treatment of lung cancer
Lung cancer is the leading cause of cancer-related death globally. Currently, lung cancer is mainly treated by radiotherapy, chemotherapy and surgery. Approximately 40% of patients are prone to relapse, and the survival rate in the advanced stages is less than 15%, indicating poor treatment outcomes...
Saved in:
| Main Authors: | Zhang Jinpeng, Zhu Xiaoshan, Duan Jiangyi, Bu Jianxue, Ma Li |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of Journal of Colorectal & Anal Surgery
2024-02-01
|
| Series: | 结直肠肛门外科 |
| Subjects: | |
| Online Access: | https://jcas.gxmuyfy.cn/cn/wqll/paper.html?id=66&cateName=2024%E5%B9%B4%20%E7%AC%AC30%E5%8D%B7%20%E7%AC%AC1%E6%9C%9F |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Research and Clinical Progress of Therapeutic Tumor Vaccines
by: Chunyan Dong, et al.
Published: (2025-06-01) -
Research progress of tumor vaccines in the treatment of prostate cancer
by: Chen Zheng, et al.
Published: (2024-02-01) -
Progress on the poxvirus vaccine
by: Mengmeng Zhao, et al.
Published: (2024-12-01) -
Serine metabolism in tumor progression and immunotherapy
by: Dong Huang, et al.
Published: (2025-04-01) -
Research Status and Progress on Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma in Hebei Province
by: Xiaoyang DUAN, et al.
Published: (2025-02-01)